Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

FDA OKs Once-Daily Form of Drug Sustiva

February 5, 2002

US drug giant Bristol-Myers Squibb Co. said on Monday that the Food and Drug Administration has approved a once-daily tablet of its HIV treatment Sustiva. Currently the drug must be taken in the form of three 200-milligram tablets daily. The New York-based company said the 600-milligram tablet will make it easier for HIV patients to comply with their drug regimens. The 600-mg tablet will be available late this month in one-month supplies of 30 per bottle. The 200-mg version will continue to be offered for those who prefer it.


Back to other CDC news for February 5, 2002

Previous Updates

Adapted from:
Reuters
02.04.02



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

Tools
 

Advertisement